NDC 73606-020
Syfovre 15 mg per 0.1 mL injection, solution
On the label: Apellis Pharmaceuticals, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Bachem AG | Bubendorf, Switzerland | Makes the active ingredient | Problems found, fixed voluntarilyAug 16, 2024 · 4 inspections |
| Juzen Chemical Corporation | Toyama-city, Japan | Makes the active ingredient | Problems found, fixed voluntarilyAug 1, 2025 · 6 inspections |
| Lifecore Biomedical, LLC | Chaska, MN, United States | Makes it | Problems found, fixed voluntarilyMar 12, 2025 · 4 inspections |
| Eurofins Advantar Laboratories, LLC | San Diego, CA, United States | Tests it | Problems found, fixed voluntarilyJun 30, 2026 · 3 inspections |
| Eurofins Lancaster Laboratories, LLC | Lancaster, PA, United States | Tests it | Problems found, fixed voluntarilyAug 26, 2025 · 8 inspections |
| Lifecore Biomedical Operating Company, Inc. | Chaska, MN, United States | Tests it | Problems found, fixed voluntarilyMar 12, 2025 · 4 inspections |
| Micro Measurement Laboratories, Inc. | Wheeling, IL, United States | Tests it | Problems found, fixed voluntarilyApr 28, 2026 · 9 inspections |
| Packaging Coordinators, LLC | Philadelphia, PA, United States | Packages it | Problems found, fixed voluntarilyJan 31, 2025 · 6 inspections |
| West Services and Solutions LLC | Exton, PA, United States | Tests it | No problems foundMar 9, 2026 · 5 inspections |
Product details
- Generic drug
- Pegcetacoplan: every company that makes it
- Form
- injection, solution, intravitreal
- Strength
- 15 mg per 0.1 mL
- Approval
- NDA NDA217171
- On the market since
- Feb 17, 2023
- Package NDCs
73606-020-0173606-020-0273606-020-1173606-020-12- Official label
- DailyMed (National Library of Medicine), updated Sep 16, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?